FDA Adverse Event Injury Summary report: N

COMPLETE SE STENT SYSTEM

MDR report key: 1595186 · Received February 3, 2010

Report

Report Number
2953200-2010-00137
Event Type
Injury
Date Received
February 3, 2010
Date of Event
November 12, 2009
Report Date
January 8, 2010
Manufacturer
MEDTRONIC CARDIOVASCULAR
Product Code
FGE
PMA / PMN Number
K062264
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 1

(B) (4) EVALUATION RESULTS: (REVASCULARIZATION).

Description of Event or Problem · 1

THE PT HAD 2 COMPLETE SE STENTS IMPLANTED, 1 STENT IMPLANTED TO THE POPLITEAL ARTERY (PPA) AND 1 IMPLANTED TO THE MID/DISTAL SUPERFICIAL FEMORAL ARTERY (SFA) (MFR REPORT # 2953200-2009-01786). BOTH LESIONS ARE REPORTED TO BE SEVERELY CALCIFIED. THE STENTS WERE DEPLOYED SUCCESSFULLY. ONE MONTH POST INDEX PROCEDURE, THE PT REQUIRED HOSPITALIZATION OF CARDIAC ISCHEMIA. VASCULAR INTERVENTION WAS PERFORMED. THE INVESTIGATOR INDICATED THAT THE REPORTED EVENT WAS NOT RELATED TO THE STUDY DEVICE. APPROX 6.5 MONTHS POST INDEX PROCEDURE, THE PT SUFFERED SEVERE CLAUDICATION IN THE RIGHT CALF/BUTTOCK. THE PT WAS HOSPITALIZED AND TARGET VESSEL REVASCULARIZATION WAS PERFORMED. THE PT IS CONTINUING WITH TREATMENT. THE INVESTIGATOR INDICATED THAT THE REPORTED EVENT WAS RELATED TO THE STUDY STENT. COMPLETE SE IS NOT APPROVED FOR USE IN THE U.S. FOR SFA INDICATION, BUT IS SIMILAR TO COMPLETE SE WHICH IS APPROVED FOR BILIARY INDICATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 COMPLETE SE STENT SYSTEM FGE MEDTRONIC CARDIOVASCULAR NA V00164466

Patients

Seq Age Sex Outcome Treatment
1 72 YR Male Required Intervention ASPIRIN 24 HRS PRIOR TO EVENT. | THE PT WAS TAKING CLOPIDOGREL &.| THE PT WAS TAKING CLOPIDOGREL &| ASPIRIN 24 HRS PRIOR TO EVENT.